ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BNTX BioNTech SE

93.35
0.00 (0.00%)
Pre Market
Last Updated: 09:07:58
Delayed by 15 minutes
Name Symbol Market Type
BioNTech SE NASDAQ:BNTX NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 93.35 92.74 92.93 0 09:07:58

CDC Panel Recommends Giving First Covid Vaccines to Health Workers, Nursing Homes--Update

01/12/2020 11:30pm

Dow Jones News


BioNTech (NASDAQ:BNTX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more BioNTech Charts.
By Peter Loftus and Jared S. Hopkins 

A federal vaccine advisory panel voted Tuesday to recommend that health-care workers and residents of long-term care facilities be the first to receive any Covid-19 vaccine doses from the limited supply that will be available initially.

The recommendations from the panel, which advises the Centers for Disease Control and Prevention, apply to about 21 million health-care workers and three million residents of long-term care facilities.

Federal officials have said they expect there will be about 40 million doses available in December. The initial vaccines available are given in two doses three or four weeks apart, so there may be enough for 20 million people to be vaccinated in the early weeks. Supplies are expected to increase during 2021.

U.S. health regulators are expected to decide in the coming weeks whether to authorize the emergency use of two Covid-19 vaccines, one from Pfizer Inc. and BioNTech SE and another from Moderna Inc. The companies have been manufacturing doses but it could take several months to make enough to vaccinate the broader population.

The CDC usually follows the recommendation of its advisory panel, and its decision is expected by the time any shots are authorized. States, which will ultimately decide how to allocate Covid-19 vaccine supplies, have been waiting for the recommendations. States have until Friday to indicate to the federal government where they want their initial doses sent.

Betsy McKay contributed to this article.

Write to Peter Loftus at peter.loftus@wsj.com and Jared S. Hopkins at jared.hopkins@wsj.com

 

(END) Dow Jones Newswires

December 01, 2020 18:15 ET (23:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year BioNTech Chart

1 Year BioNTech Chart

1 Month BioNTech Chart

1 Month BioNTech Chart

Your Recent History

Delayed Upgrade Clock